Cell and Gene Therapy in Parkinson's Disease Market to Register Stunning Growth During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
MeiraGTx Holdings plc - Ordinary Shares (MGTX)
Company Research
Source: Yahoo! Finance
the launch of upcoming therapies and the increasing prevalence of the disease. With the launch of emerging therapies, many new players are expected to enter the cell and gene therapy in Parkinson's disease market space. New York, USA, July 22, 2024 (GLOBE NEWSWIRE) -- Cell and Gene Therapy in Parkinson's Disease Market to Register Stunning Growth During the Study Period (2020–2034) | DelveInsight The cell and gene therapy in Parkinson's disease market size is projected to grow significantly during the forecast period (2024–2034), owing to the launch of upcoming therapies and the increasing prevalence of the disease. With the launch of emerging therapies, many new players are expected to enter the cell and gene therapy in Parkinson's disease market space. DelveInsight's Cell and Gene Therapy in Parkinson's Disease Market Insights report includes a comprehensive understanding of current treatment practices, emerging cell and gene therapy in Parkinson's disease, market share of ind
Show less
Read more
Impact Snapshot
Event Time:
MGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTX alerts
High impacting MeiraGTx Holdings plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MGTX
News
- Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts? [Yahoo! Finance]Yahoo! Finance
- MeiraGTx Holdings plc (NASDAQ: MGTX) had its price target lowered by analysts at Royal Bank of Canada from $11.00 to $9.00. They now have an "outperform" rating on the stock.MarketBeat
- MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi [Yahoo! Finance]Yahoo! Finance
- MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results [Yahoo! Finance]Yahoo! Finance
MGTX
Earnings
- 8/12/24 - Miss
MGTX
Sec Filings
- 8/14/24 - Form SC
- 8/14/24 - Form 4
- 8/13/24 - Form 8-K
- MGTX's page on the SEC website